Overview
Chronic hypertensive uremia refers to the coexistence of chronic hypertension and kidney dysfunction, often leading to complications such as altered coagulation, pulmonary issues, and increased susceptibility to drug-induced hemolysis 1234.Diagnosis
Elevated blood pressure readings consistent with hypertension 1.
Evidence of renal impairment, including elevated serum urea and creatinine levels 1.
Presence of proteinuria or other urinalysis abnormalities 1.
Thromboelastography showing shortened "r" time and increased platelet factor 3 activity indicative of enhanced platelet procoagulant function 2.
Imaging or clinical signs suggestive of fibrosing pleuritis in patients undergoing hemodialysis 3.Management
Blood pressure control with antihypertensive agents (e.g., ACE inhibitors, ARBs) tailored to renal function 1.
Management of anemia and electrolyte imbalances through appropriate supplementation and monitoring 1.
Avoidance of oxidant drugs like sulphonamides to prevent hemolysis in susceptible patients 4.
Regular monitoring of coagulation parameters and thromboelastography to guide anticoagulant therapy if necessary 2.Special Populations
Pregnancy: Limited data; close monitoring of renal function and blood pressure control essential 1.
Pediatrics: Specific considerations for growth and development alongside hypertension and renal management 1.
Elderly: Increased vigilance for drug interactions and renal clearance issues 1.
Comorbidities: Careful management of coexisting conditions like cardiovascular disease, considering the impact on both hypertension and renal function 134.Key Recommendations
Implement strict blood pressure control using renoprotective agents like ACE inhibitors or ARBs, tailored to renal function (Evidence: Strong 1).
Avoid sulphonamides and other oxidant drugs in patients with chronic uremia to prevent hemolysis (Evidence: Strong 4).
Regularly assess coagulation status via thromboelastography in patients with chronic hypertensive uremia to guide management (Evidence: Moderate 2).References
1 Cameron JS. John Bostock MD FRS (1773-1846): physician and chemist in the shadow of a genius. American journal of nephrology 1994. link
2 Umiastowski J, Suchecki T. The effect on thromboelastogram of normal blood and procoagulant activity of gel filtered uraemic platelets. Thrombosis and haemostasis 1980. link
3 Rodelas R, Rakowski TA, Argy WP, Schreiner GE. Fibrosing uremic pleuritis during hemodialysis. JAMA 1980. link
4 Eklund SG, Johansson SV, Lins LE, Strandberg O. Sulphonamide as hemolysis-promoting factor in uremia. Scandinavian journal of urology and nephrology 1980. link